Completed PHASE2 INTERVENTIONAL 3-arm NCT01282606

Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation

An Open Label, Non-randomized Dose-escalation Study to Assess Safety and Tolerability of SI-6603 in Patients With Lumbar Disc Herniation (Phase II Study)

Sponsor: Seikagaku Corporation

Conditions Lumbar Vertebra Hernia

Interventions SI-6603

Updated 8 times since 2017 Last updated: Mar 21, 2023 Started: Dec 31, 2007 Primary completion: Aug 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lumbar Vertebra Hernia, this trial is completed. The trial is conducted by Seikagaku Corporation and has accumulated 8 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2023 — Jul 2024 [monthly]

Completed PHASE2
Apr 2022 — Apr 2023 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seikagaku Corporation

Data source: Seikagaku Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Encinitas, United States